NCT05241873 2025-02-10(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion MutationsBlueprint Medicines CorporationPhase 1 Terminated103 enrolled
NCT05153408 2023-06-18(HARMONY) Study of BLU-701 in EGFR-mutant NSCLCBlueprint Medicines CorporationPhase 1 Terminated20 enrolled
NCT03351842 2017-12-19Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%Shanghai Pulmonary Hospital, Shanghai, ChinaPhase 2 Recruiting460 enrolled